P198 An inflammatory serum metabolomic signature predicts response to vedolizumab treatment in people with Crohn’s Disease

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2022-01, Vol.16 (Supplement_1), p.i257-i259
Main Authors: Radford-Smith, D, Yates, A, Hageman, I, Joustra, V, Li Yim, A, Davids, M, Henneman, P, Hakvoort, T, D’Haens, G, de Jong, W, Anthony, D, Satsangi, J, Probert, F
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjab232.325